Why participate?

The PCOR-ANZ is an important tool to monitor and benchmark the quality of treatment and care of men diagnosed with prostate cancer, across Australia and New Zealand. Participation in PCOR-TAS and PCOR-ANZ will allow hospitals and clinicians to compare their standard of care to other sites within Tasmania and across Australia and New Zealand.

What is the process of hospital consent?

Hospitals treating men with prostate cancer will be identified via notifications at the Cancer Registry of Tasmania. Treating hospitals will be approached by PCOR-TAS in order to obtain consent for a trained Data Collector to access medical files of consenting patients. This study has been approved by the Tasmanian Health and Medical Human Research Ethics Committee.

How will patients consent?

Patients that have received treatment at a participating hospital will be presented with a Patient Information Consent Form and a letter of invitation to participate. An opt-out consent will be employed and two weeks after mail-out will be given before data can be extracted. Should the patient wish to opt-out at any stage after this time, they may do so by contacting PCOR-TAS.

What is required of the participating hospital?

As a participating hospital an appropriate lead clinician will need to be identified (for example, the Head of Urology or Radiation Oncology departments). This lead clinician will be responsible for ensuring that hospital staff allows data to be available to PCOR-TAS Data Collectors.